Search

Search Results

• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  2031

  PDF: 504
• 

  A comprehensive evaluation of the transition to a biosimilar of adalimumab in rheumatoid arthritis and psoriatic arthritis: a single-center experience with a focus on imaging outcomes

  Rodrigo Garcia-Salinas, Sebastian Magri, Alvaro Ruta, Santiago Ruta

  08-05-2025

  https://doi.org/10.4081/reumatismo.2025.1748

  1207

  PDF: 67
• 

  Etanercept biosimilar associated with Guillain-Barré syndrome: insights from a case

  V. Shobha, A.M. Desai, T. Matthew

  99-102

  09-07-2019

  https://doi.org/10.4081/reumatismo.2019.1115

  1423

  PDF: 903